对《常规重新筛查潜伏性结核在接受生物制剂治疗的慢性免疫介导性炎症疾病患者中效用较低：一项单中心回顾性队列研究》的回复 - Suppr

Reply to "Routine Re-screening for Latent Tuberculosis Has Low Utility in Patients With Chronic Immune-Mediated Inflammatory Diseases Treated With Biologics: A Single Center Retrospective Cohort Study".

作者信息

Khanna Urmi, Fernandez Anthony P

机构信息

Division of Dermatology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, New York.

Department of Dermatology, Cleveland Clinic, Ohio; Department of Pathology, Cleveland Clinic, Ohio.

出版信息

J Am Acad Dermatol. 2022 Dec;87(6):1437-1438. doi: 10.1016/j.jaad.2022.07.051. Epub 2022 Aug 19.

DOI:10.1016/j.jaad.2022.07.051

PMID:35995087

Abstract

摘要

相似文献

Reply to "Routine Re-screening for Latent Tuberculosis Has Low Utility in Patients With Chronic Immune-Mediated Inflammatory Diseases Treated With Biologics: A Single Center Retrospective Cohort Study".

J Am Acad Dermatol. 2022 Dec;87(6):1437-1438. doi: 10.1016/j.jaad.2022.07.051. Epub 2022 Aug 19.

Reply to "Routine rescreening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study".

J Am Acad Dermatol. 2022 Dec;87(6):e239-e240. doi: 10.1016/j.jaad.2022.06.1204. Epub 2022 Aug 7.

Routine rescreening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study.

J Am Acad Dermatol. 2022 Oct;87(4):841-843. doi: 10.1016/j.jaad.2022.05.027. Epub 2022 May 18.

Approaches to screening for latent tuberculosis infection in patients with immune-mediated disease prior to commencement of biologics.

Hong Kong Med J. 2020 Apr;26(2):93-94. doi: 10.12809/hkmj205096.

Reply to: "Evidence-based guidelines for tuberculosis screening before biologic treatment initiation".

J Am Acad Dermatol. 2020 Jul;83(1):e27-e28. doi: 10.1016/j.jaad.2020.03.039. Epub 2020 Mar 25.

Tuberculosis screening guidelines should be updated and quantiferon test should be a prerequisite prior to the initiation of treatment of psoriasis with biological agents.

Eur Rev Med Pharmacol Sci. 2022 Dec;26(23):8788-8794. doi: 10.26355/eurrev_202212_30550.

Don't Be Late on Latent TB: Inconsistent Tuberculosis Screening in IBD Patients on Biologics.

J Crohns Colitis. 2019 Feb 1;13(2):270. doi: 10.1093/ecco-jcc/jjy141.

An audit of compliance with tuberculosis screening prior to treatment with biologics in psoriasis.

Clin Exp Dermatol. 2018 Jul;43(5):611. doi: 10.1111/ced.13413. Epub 2018 Feb 15.

Prevalence of latent tuberculosis infection in patients with moderate to severe psoriasis taking biologic therapies in a dermatologic private practice in Miami, Florida.

Int J Dermatol. 2015 Jul;54(7):846-52. doi: 10.1111/ijd.12679.

Risk for latent tuberculosis infection reactivation among patients with psoriasis on biologics treatment: A meta-analysis.

J Infect. 2024 Sep;89(3):106226. doi: 10.1016/j.jinf.2024.106226. Epub 2024 Jul 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Reply to "Routine Re-screening for Latent Tuberculosis Has Low Utility in Patients With Chronic Immune-Mediated Inflammatory Diseases Treated With Biologics: A Single Center Retrospective Cohort Study".

作者信息

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Reply to "Routine Re-screening for Latent Tuberculosis Has Low Utility in Patients With Chronic Immune-Mediated Inflammatory Diseases Treated With Biologics: A Single Center Retrospective Cohort Study".

作者信息

机构信息

出版信息

相似文献